Blood Group Genotyping for Sickle Cell and Thalassaemia

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Contract ()
Duration
not specified
Value
£141K
Sector
MISCELLANEOUS
Published
10 Jun 2026
Delivery
not specified
Deadline
n/a

Related Terms

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

Embedding blood group genotyping into routine practice. The primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping. Due to delays arising from administrative and operational circumstances, NHS England awarded this contract to commencing 25 June 2025 until 31 March 2026.

Award Detail

1 NHSBT (Bristol)
  • Blood Group Genotyping for Sickle Cell and Thalassaemia
  • Reference: 1
  • Value: £140,671

CPV Codes

  • None found

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-05f01d
  • FTS 054590-2026

Domains